Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E McCoy

Showing results (311-320 of 331) with videos related to

Pageof 34
Sort By:
Iscience|January 2, 2023
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profilesEmma Touizer, Aljawharah Alrubayyi, Rosemarie Ford, et al.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Nature|June 30, 2021
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2Dami A Collier, Isabella A T M Ferreira, Prasanti Kotagiri, et al.
EMBO Reports|August 24, 2022
Evolutionary remodelling of N-terminal domain loops fine-tunes SARS-CoV-2 spikeDiego Cantoni, Matthew J Murray, Mphatso D Kalemera, et al.
Nature Communications|March 6, 2021
Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophagesJennifer K Dowling, Remsha Afzal, Linden J Gearing, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Plos Pathogens|September 24, 2020
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsSuzanne Pickering, Gilberto Betancor, Rui Pedro Galão, et al.
Medrxiv : the Preprint Server for Health Sciences|January 5, 2021
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptationS A Kemp, D A Collier, R Datir, et al.
Nature|November 10, 2021
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2Leo Swadling, Mariana O Diniz, Nathalie M Schmidt, et al.
Pageof 34

Showing results (311-320 of 331) with videos related to

Sort By:
Pageof 34
Iscience|January 2, 2023
Attenuated humoral responses in HIV after SARS-CoV-2 vaccination linked to B cell defects and altered immune profilesEmma Touizer, Aljawharah Alrubayyi, Rosemarie Ford, et al.
Biorxiv : the Preprint Server for Biology|February 10, 2021
Impact of the B.1.1.7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 SpikeCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Immunity|September 13, 2016
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing AntibodiesJon M Steichen, Daniel W Kulp, Talar Tokatlian, et al.
Nature|June 30, 2021
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2Dami A Collier, Isabella A T M Ferreira, Prasanti Kotagiri, et al.
EMBO Reports|August 24, 2022
Evolutionary remodelling of N-terminal domain loops fine-tunes SARS-CoV-2 spikeDiego Cantoni, Matthew J Murray, Mphatso D Kalemera, et al.
Nature Communications|March 6, 2021
Mitochondrial arginase-2 is essential for IL-10 metabolic reprogramming of inflammatory macrophagesJennifer K Dowling, Remsha Afzal, Linden J Gearing, et al.
Immunity|April 9, 2021
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variantCarl Graham, Jeffrey Seow, Isabella Huettner, et al.
Plos Pathogens|September 24, 2020
Comparative assessment of multiple COVID-19 serological technologies supports continued evaluation of point-of-care lateral flow assays in hospital and community healthcare settingsSuzanne Pickering, Gilberto Betancor, Rui Pedro Galão, et al.
Medrxiv : the Preprint Server for Health Sciences|January 5, 2021
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptationS A Kemp, D A Collier, R Datir, et al.
Nature|November 10, 2021
Pre-existing polymerase-specific T cells expand in abortive seronegative SARS-CoV-2Leo Swadling, Mariana O Diniz, Nathalie M Schmidt, et al.
Pageof 34